The prevalence of metabolic syndrome and the associated factors in a multiethnic upper-middle-income country in Asia: findings from a nationwide community-based study in 2023.

ABSTRACT:

Background

Metabolic syndrome (MetS) is a constellation of cardio-metabolic risk factors that predispose individuals to cardiovascular disease and type 2 diabetes. However, the current prevalence of MetS in Malaysia is unknown. Thus, we aimed to determine the prevalence of MetS and its associated factors among the adult population in Malaysia.

Methods

This was a nationwide community-based cross-sectional study in Malaysia with two-stage stratified random sampling in 2023. MetS was defined based on the Harmonised Joint Interim Statement that required ≥ 3 metabolic risk abnormalities: abdominal obesity, elevated blood glucose, blood pressure, triglycerides, and low HDL-cholesterol. Complex sample analyses, including multiple binary logistic regression, were used to achieve the

SUBMITTER: Wan KS 

PROVIDER: S-EPMC12013071 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature